IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) IMPAX CV 2.08

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2014-11-24 for IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) IMPAX CV 2.08 manufactured by Agfa Healthcare Corporation.

Event Text Entries

[16544490] Agfa submitted mdr report # 1225058-2010-00001 to the fda on june 07, 2010 for a site in the us. A (b)(6) occurrence is being reported for the same issue/same device: impax cv results management administration tool (rmat). This is an internal discovery determined during the implementation of the associated problem correction plan, rmat verification, as reported in fda z-2112-10.
Patient Sequence No: 1, Text Type: D, B5


[16588573] An agfa clinical analyst performed a retro-analysis and reported the findings to agfa service an agfa product quality manager. Agfa's investigation into this occurrence or rmat customizations has revealed that this specific change had the potential to introduce clinical inaccuracies in patient reports. Specifically: no vegetation is observed on the mitral valve: has been changed to:" there are echo findings consistent with a mass involving the anterior leaflet of the mitral valve". The original sentence describes the absence of vegetation on the mitral valve. This has been changed to contain contradictory clinical findings which indicate the presence of a mass on the anterior mitral valve leaflet. This is clinically inaccurate and not what the reading cardiologist intended. Potential impact: if the change was made after reports had been generated with the original sentence selected, those reports prior to the change could display incorrect clinical data if viewed in rm or if used as a template for a repeat study on that patient. As soon as agfa is made aware of any affected reports related to this specific finding, follow-up mdrs will be submitted for each associated study date and respective medical record number/s (mrn) identified. A reportable correction is underway for this issue and has been reported to the fda via reference # z-2112-10. Agfa will follow the rmat post market verification work instructions to correct the sentence finding. Any further investigation for the site described in this report will be documented in the ongoing cfr part 806 reporting.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1225058-2014-06289
MDR Report Key4293418
Report Source07
Date Received2014-11-24
Date of Report2014-11-24
Date of Event2014-10-31
Date Mfgr Received2014-10-31
Device Manufacturer Date2002-03-01
Date Added to Maude2014-12-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMRS. DEBORAH HUFF
Manufacturer Street10 SOUTH ACADEMY STREET
Manufacturer CityGREENVILLE SC 29601
Manufacturer CountryUS
Manufacturer Postal29601
Manufacturer Phone8644211754
Single Use0
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08)
Generic NamePICTURE ARCHIVING AND COMMUNICATION
Product CodeLLX
Date Received2014-11-24
Model NumberIMPAX CV 2.08
Catalog NumberNA
Lot NumberNA
ID NumberNA
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerAGFA HEALTHCARE CORPORATION
Manufacturer Address1 CROSSWIND RD. MISQUAMICUT RI 02891 US 02891


Patients

Patient NumberTreatmentOutcomeDate
10 2014-11-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.